Device Co. Pleads Guilty To Hiding Toxicity Data From FDA
San Diego-based Valor Medical Inc., which faces sentencing on Feb. 19, accepted responsibility for failing to tell the FDA about in vitro tests that raised red flags about its liquid polymer product Neucrylate, which is intended to treat aneurysms.
The tests were needed to...
To view the full article, register now.